glp-1 receptor agonist news agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 Muscle Loss Explained |

After a disagreement, Hans Christian Hagedorn fired chemist and pharmacist Thorvald Pedersen in 1924

DEXA scan and/or Bioimpedance Analysis/BIA) throughout treatment

Burke, J

Reflecting a growing acceptance of obesity as a legitimate medical condition, at least in the United State, a 2024 employer health benefits survey found that 61% of respondents support expanding Medicare (federal health insurance program primarily for individuals aged 65 and older) coverage beyond treatment for T2DM to include GLP-1 therapies for weight management in overweight individuals (Kaiser Family, F, 2024)

Heres a quick overview: Sometimes, one or more of these medications may be in shortage , making your Rx difficult to fill at the pharmacy

Here are the concrete steps you should take if your coverage has been affected